AMD's Data Center Bet Is Paying Off — and Narrowing the Story
Bayer's Pharma Margin Upgrade Faces a Cash-Flow Reality Check
R&S Group’s Capital Markets Day demonstrates how the Group is ‘Stepping up in Power’
Deutsche Telekom: A Buyback Already Executed, a Satellite Bid Still Only Studied
Munich Re's €1.7 Billion Quarter Meets a Harder Renewal Market
IREN's Debt Bill Has Doubled — November 5 Is Where the Story Gets Audited
Night Shift Walks Out at Ingolstadt: 3,000 Audi Workers Press 5% Pay Claim as Talks Turn Bitter
Innodata's November 5 Test: Separating a Filing From a Rumor
Allianz Heads to November 12 With Fresh Distribution Wins and a London Court Setback
Erste Group Launches Polish Buyout Offer as Barclays Lifts Target to EUR 137
Gold's Squeeze Has Two Fathers: Margin Calls and the Rate Trap
Renk Heads to Euronaval With a Signed Submarine Order and a £700 Million Question Mark
Silver's Crosscurrents: Chinese Output Slips, Solar Demand Sags, and Speculators Head for the Exits
TSMC Faces Twin Tests: AI Spending Scrutiny and Construction Safety Demands
Berkshire's Legal Reckoning and Its Defensive Bid: Two Forces Pulling the Stock
Deutz Balances Boardroom Confidence, Analyst Optimism and a Hydrogen Research Milestone
Marvell's Lumentum Arithmetic: Two Forecasts, Two Clocks, One $115 Billion Question
Evotec's Beat-and-Hold Quarter Sets Up a November 5 Reckoning
Take-Two's GTA VI Hype Meets a Hard Deadline: What the November Numbers Can and Cannot Prove
D-Wave Quantum: A Rebound, a Cut Target and a Korean Handshake All Await the Same November 10 Test
Mercedes-Benz Redraws Its Map: Less China, Smarter Glass, and a Charging Handover
Evonik's Essen Silicone Plant and 40% Earnings Jump Test the Standalone Story
Novo Nordisk's Buyback Runs Into Lilly's Trial Data as Third-Quarter Print Lands
Nebius Stock: A 7.5% Rebound, a 50-Megawatt Handshake, and a November 12 Date With the Numbers
Rheinmetall's Next Test Is Execution, Not Announcements
Nel ASA Pairs a 500 MW Herøya Build-Out With a Leadership Handover as Orders Outrun Billings
IREN's $363 Million Lifeline Is Signed — Now Comes the Reckoning With the Numbers
BioNTech Hands Roche Its PDAC Tab as a One-Off Accounting Swing Masks a Thinner Quarter
ServiceNow's Buy Rating Holds at $170 — but the Fourth-Quarter cRPO Guide Is the Real Test